Karyopharm Therapeutics Inc. | KPTI

Daily Technical Analysis of Karyopharm Therapeutics Inc.

Karyopharm Therapeutics is down a bit on the day, funds flowing out kept the price down -1.42% since yesterday.

The Drug Manufacturers company isn't at an immediate support or resistance level that might be predictive. KPTI hasn't established a very clear directional momentum over the last few months. So it's not clear exactly where it's going. KPTI might find some support at the 5.17 level, buyers might push the price back up from here. But it's not very clear what will happen.

Analyst Ratings for Karyopharm Therapeutics By Price Target And Rating

Karyopharm Therapeutics has an overall positive view by the analysts. The current Analysts Sentiment Score is 115.98. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2023-02-22 HC Wainwright reiterated their rating of Buy and added a price target of $16.00. Morgan Stanley announced a lowering of their price target to $5.00 from $7.00 on 2023-01-27. Piper Sandler initiated a rating of Overweight on 2023-01-19 and added a price target of $8.00. SVB Leerink dropped their price target by -16.67% to $5.00 on 2023-01-10. Royal Bank of Canada announced an upgrade on 2022-11-04 from Sector Perform to Outperform and moved up their price target to $10.00 which is a 42.86% increase. On 2022-08-05 Barclays lowered their price target by -42.86% to $8.00. Robert W. Baird provided a price target decease of -17.65% to $14.00 from $17.00 on 2022-08-05. On 2022-04-11 Canaccord Genuity Group lowered their price target by -50% to $10.00. JPMorgan Chase & Co. announced an upgrade on 2022-02-09 from Underweight to Neutral and they set their price target at $8.00. Wedbush provided a price target boost of 36.91% to $26.00 from $18.99 on 2020-06-23.

Company	Ratings Score ? Composite analyst sentiment score	Positive Ratings	Negative Ratings	Boost Price Target	Lower Price Target
KPTI	115.98	147.3	0	143.18	-58.52

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2022-11-28)

Company	YOY Growth Score (typical -20 to +20)	Revision Directions (-6 to +6)
KPTI	2.18	8.91

Short interest for Karyopharm Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company	Short Score (typical 1-15) ? We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)	Short Interest	Days to Cover	Rate of Change	Shares Short
KPTI	18.65	%23	7.8	27.06	16430000

How Karyopharm Therapeutics compares to the broader Healthcare sector and the more specific Drug Manufacturers industry

Segment	Count	1 Day%	5 Day	1 Month	3 Month	6 Month	1 Year	RSI	3mo S-momo ? Smooth Momentum is our proprietary technical indicator that looks for momentum with the greatest consistency and steady velocity. We have penalized dramatic swings and fluctuations. If the momentum is too high and an asset spikes upward, this is often unreliable and collapses back down. But the smoothed momentum provides the highest probability of continuing into the near future with the same directional rate of change. Several complex factors are weighted by neural nets to maximize probabilistic accuracy. It works the same with positive or negative directions.	6mo S-momo	1yr S-momo	Resistance ? Support and Resistance levels are determined by previous high and low points. You may be familiar with traders drawing lines across charts where several peaks or valleys occur in the same range. This helps us understand the trading range of an asset where the market doesn't perceive it to be worth more or less than a certain price level. When it nears the boundaries of this range the probability of reversal can increase. Our neural nets create scores for this measure based on many factors such as the frequency, recency, size, consistency, etc of previous reversal points.	Support	Demark Sell ? Demark 9 indicators are designed to look for exhaustion in the selling or buying trend which can often be predictive of a reversal point. This indicator is triggered when there are 9 consecutive days where the closing price is higher/lower than the closing price 4 days ago. Like all indicators, it is best used in combinations with other factors.	Demark Buy	Short Interest	Analysts Ratings ? We track several different measures of analyst sentiment including ratings and price targets. To create a composite Analyst Sentiment Score, we weight several factors such as the recent rate of change which can be more predictive than the absolute level. We also weight each analyst's opinion based on their historic accuracy. We built in a time decay function to ensure that the rating reflects the current sentiment levels. Typical range (-80 to +80)
Drug Manufacturers Show Me Companies With: S-Momentum: Highest \| Lowest At Bottom Support At Top Resistance RSI Highest \| Lowest 1 Day Growth: Highest \| Lowest 5 Day Growth: Highest \| Lowest 1 Month Growth: Highest \| Lowest 6 Month Growth: Highest \| Lowest List All Stocks	52	1.81	-0.49	-3.10	2.64	-8.43	-31.11	34.33	-16.25	-15.70	-18.60	-36397.67	-2771.42	0.00	27.88	4.93	23.35
Healthcare Show Me Companies With: S-Momentum: Highest \| Lowest At Bottom Support At Top Resistance RSI Highest \| Lowest 1 Day Growth: Highest \| Lowest 5 Day Growth: Highest \| Lowest 1 Month Growth: Highest \| Lowest 6 Month Growth: Highest \| Lowest List All Stocks	617	2.00	-0.17	-8.49	2.07	-6.13	-23.93	31.85	-11.33	-14.45	-14.07	-36805.91	-4054.41	1.05	22.33	5.93	36.37

Social Sentiment for Karyopharm Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker	Social Sentiment(1-10)
KPTI	5.00

Companies with the highest correlation to Karyopharm Therapeutics

Company	Score	1 Day%	5 Day	1 Month	3 Month	6 Month	1 Year	RSI	3mo S-momo ? Smooth Momentum is our proprietary technical indicator that looks for momentum with the greatest consistency and steady velocity. We have penalized dramatic swings and fluctuations. If the momentum is too high and an asset spikes upward, this is often unreliable and collapses back down. But the smoothed momentum provides the highest probability of continuing into the near future with the same directional rate of change. Several complex factors are weighted by neural nets to maximize probabilistic accuracy. It works the same with positive or negative directions.	6mo S-momo	1yr S-momo	Resistance ? Support and Resistance levels are determined by previous high and low points. You may be familiar with traders drawing lines across charts where several peaks or valleys occur in the same range. This helps us understand the trading range of an asset where the market doesn't perceive it to be worth more or less than a certain price level. When it nears the boundaries of this range the probability of reversal can increase. Our neural nets create scores for this measure based on many factors such as the frequency, recency, size, consistency, etc of previous reversal points.	Support	Demark Buy	Short Interest Score
SGMO \| Sangamo Therapeutics, Inc	0.79	-1.55	-12.04	-34.71	-39.49	-64.15	-67.13	9	-49.80	-90.58	-41.56	-39882.11	0.00	0	8.30077
HRTX \| Heron Therapeutics, Inc.	0.7	5.05	-7.42	-19.07	-16.60	-53.21	-57.32	41	-61.34	-59.69	-64.43	-42286.70	0.00	0	19.9129
SPPI \| Spectrum Pharmaceuticals	0.68	3.19	6.54	5.43	144.26	-22.11	-8.05	38	33.67	16.54	29.90	-11804.95	-2809.89	0	3.0434
GTHX \| G1 Therapeutics, Inc. Com	0.66	7.14	-3.67	-16.45	-45.03	-77.89	-61.96	30	-70.01	-64.39	-39.25	-25686.68	0.00	0	7.14626
FGEN \| FibroGen, Inc	0.64	-2.95	-2.95	-13.81	22.38	58.19	50.47	5	43.21	77.22	142.23	-2617.70	-13635.45	0	8.3485
KURA \| Kura Oncology, Inc.	0.64	0.57	5.56	3.18	4.49	-2.76	-22.39	44	-32.19	-18.25	-22.74	-17310.97	176.83	125	7.01582
ACAD \| Acadia Pharmaceuticals In	0.63	-1.57	-2.02	2.58	22.95	7.10	-23.36	45	46.20	18.02	20.82	-1592.04	-7567.79	0	5.77115
SAGE \| Sage Therapeutics, Inc	0.63	-1.57	-0.07	2.61	8.22	4.92	28.84	54	20.13	16.62	33.67	-4282.46	-5290.62	0	8.58313

Top 3 correlating companies

See full charts for all peers

Research

Estimates

Ratings

Short Interest

Smart Money

Options

Financials

Social

Misc